Insider Transactions in Q2 2023 at Bio Rad Laboratories, Inc. (BIO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Michael Crowley EVP, GBL Commercial Operations |
SELL
Open market or private sale
|
Direct |
500
-7.65%
|
$189,500
$379.39 P/Share
|
|
Jun 06
2023
|
Ajit Ramalingam SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
198
-54.29%
|
$72,864
$368.38 P/Share
|
|
May 03
2023
|
Steven D Schwartz > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
320
-17.6%
|
$148,160
$463.86 P/Share
|
|
Apr 29
2023
|
Ajit Ramalingam SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-32.65%
|
$43,200
$450.79 P/Share
|
|
Apr 29
2023
|
Ajit Ramalingam SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
277
+48.51%
|
-
|
|
Apr 29
2023
|
Andrew J. Last EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-8.41%
|
$155,700
$450.79 P/Share
|
|
Apr 29
2023
|
Andrew J. Last EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+19.56%
|
-
|
|
Apr 08
2023
|
Ilan Daskal EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-14.0%
|
$113,238
$466.24 P/Share
|
|
Apr 08
2023
|
Ilan Daskal EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
700
+28.74%
|
-
|